Featured
#GHPRCONNECTS: SPECTRUM’S HEADING DOWN UNDER!
“One’s destination is never a place, but a new way of seeing things,” said American writer Henry Miller. And starting this week, I’ll be privy to an entirely new way of seeing things from the opposite side of the world in Sydney, Australia as a part of the 2016 GLOBALHealthPR®Professional Exchange Program with our partner,VIVA!…
Read MoreAustralian Prostate Cancer Research Clinches Global Astellas Oncology Innovation Grant
Chief Executive Officer of Australian Prostate Cancer Research (APCR), Mark Harrison, has attracted global recognition for his role in developing APCR’s interactive online prostate treatment support service, PROSTMATE™. Mr Harrison clinched one of two first prizes during a red-carpet announcement at the European Society of Medical Oncology (ESMO) Annual Congress in Copenhagen, Denmark this past…
Read MoreA huge learning curve – my first week representing VIVA! as part of the GLOBALHealthPR Professional Exchange Program
As my first week representing VIVA! Communications, Australia as part of the GLOBALHealthPR Professional Exchange Program at Spectrum in Washington D.C. draws to a close, my head is spinning with all of the health PR-related information I’ve recently gleaned. This week I’ve participated in several interesting brainstorming sessions focusing on campaign concepts and new business…
Read MoreSydney’s third annual Recovery Walk – reducing the stigma of addiction & celebrating all forms of addiction recovery
The Sydney Recovery Walk, now in its third year since inception, is set for this Sunday, September 25. The free-to-all age event aims to end the stigma associated with addiction, and to celebrate all forms of recovery. Staged by Sydney Recovery and sponsored by CEO and founder of the Exodus Foundation, Rev. Bill Crews, the…
Read MoreWhat does the King Review mean for Pharmacy in Australia – August 5, 2016
Following the release of a discussion paper dubbed the “King Review” (as the Productivity Commission’s, Stephen King headed the review panel), which has been developed to review pharmacy remuneration and regulation procedures, discussions have opened up this week around what the review recommends and how this can impact pharmacy. The Federal Government and the Pharmacy…
Read More